In the News: ivWatch Drives Diversity on WAVY TV 10

ivWatch on WAVY TV to Discuss Business Diversity

An interview with Gary Warren, president and CEO of ivWatch, and Andy Fox of WAVY TV 10, highlighted the biotech company as an example of a business driving diversity in the Hampton Roads region of Virginia. The segment features the ivWatch Model 400 and how the company is working to solve a major medical problem while creating jobs. Read the article and view the segment here.

myIV.com Encourages Patients to Take Advocate Pledge

Website for IV therapy information shares new resources and patient stories to help patients #BeYourOwnIVAdvocate

Hampton, Va. – April 25, 2018 – This month, patients were asked to take a pledge to be their own advocate by sharing their intravenous (IV) therapy stories to help others learn more about the procedure. The #BeYourOwnIVAdvocate campaign is hosted on myIV.com, a resource that provides answers to questions about IVs – from the most basic to complex. Sponsored by ivWatch, myIV.com is the first online patient resource of its kind providing visitors simplified information about IVs to foster an informed community of current and future patients.

Nearly 80 percent of all hospital patients receive an IV1, and with more than 150 million placed each year in the U.S., it is one of the most common invasive medical procedures performed. Close to 50 percent of IVs fail due to complications, such as an infiltration, when the fluid or medication intended for the vein leaks into the surrounding tissue. Every failure of an IV results in a drug delivery error and carries the potential for reduced drug effectiveness and physical harm. The myIV.com types of IV failure video educates patients on the symptoms to look out for of the most common complications, like infiltration and phlebitis.

The #BeYourOwnIVAdvocate campaign is focused on empowering patients and family caregivers with knowledge of what to know before a hospital visit. The IV 101: The Basics guide includes:

  • Why patients need IVs
  • How IVs are used
  • The different types of IVs
  • IV Risks

Barby Ingle shared a horrifying experience in a recent video interview about waking up in the middle of surgery due to an infiltration of her anesthesia medication. The WEGO Health Patient Leader stated the importance of getting informed ahead of a hospital visit, “Get the information that you need now, plant the seeds in your brain ahead of time so when you are in that emergency situation and you need help, you can remember back to what you learned on [myIV.com].”

To #BeYourOwnIVAdvocate and, take the pledge at myiv.com/be-your-own-iv-advocate/.

1. Zhang, L., Cao, S., Marsh, N., Ray-Barruel, G., Flynn, J., Larsen, E. and Rickard, C.M. (2016) Infection risks associated with peripheral vascular catheters. Journal of Infection Prevention. 17(5), p.207-213. doi: 10.1177/1757177416655472

About myIV.com
myIV.com is an online patient resource portal dedicated to empowering patients with information on all things IV, simplified. As the first website of its kind focused on IVs and IV therapy, myIV.com fills the gap in patient education and makes IVs easier to understand. myIV.com is sponsored by ivWatch. Help raise #myIVawareness on Twitter, Facebook, Instagram, LinkedIn and Pinterest. For more information, visit www.myIV.com.

MEDIA CONTACT: Amara Betoney, amara.betoney@ivwatch.com, Office (757) 224-2606, Mobile (757) 660-4949

In the News: Critical Caring

ivWatch Model 400 Featured Among Critical Care Products in Healthcare Purchasing News
A recent Healthcare Purchasing News article opens with a stat about intensive care unit (ICU) hospitals’ costs and these units being a target for new interventions that can help clinicians detect issues sooner, intervene more effectively and reduce length of stay. In the article “Critical Caring,” ivWatch Vice President of Sales and Business Development, Scott Hensley, comments on patient vulnerabilities in the critical care environment and how many hospitals are working to reduce the severity of outcomes associated with hospital-acquired conditions, including IV infiltration. The article highlights the ivWatch Model 400 as a new product category — a monitored PIV. Read the full article here.

757 Angels and ivWatch Reach Entrepreneurs at Tom Tom Fest

Local business leaders invited to speak at 7th Annual Tom Tom Founders Festival

CHARLOTTESVILLE, Va., April 16, 2018 – 757 Angels and ivWatch recently collaborated during an entrepreneurship session at Tom Tom Founders Festival, a week-long celebration of innovators, visionaries and artists who shape small cities. Part pitch competition, part case study – the organizations co-presented and provided insight into building and growing successful companies and how to foster the next generation of innovators in tech industries.

The session “An Empirical View of the Art and Science of Entrepreneurship and Investment,” was hosted by representatives from the Center for Innovative Technology’s (CIT) GAP Fund on Thursday, April 12. The Hampton Roads entrepreneur community was represented by Monique Adams, executive director of 757 Angels, a group whose membership consists of business and community leaders and Gary Warren, president and CEO of ivWatch, a medical device manufacturer and biosensor technology company. Both shared perspectives from investor and business leader sides of the table.

When asked by session panel member Jayson Rieger, a principle of the PBM Capital Group, about 757 Angels satisfaction with their investment in ivWatch, Adams responded, “ivWatch had incredible momentum early on, and they’ve sustained their competitive advantage. We are extremely pleased with our relationship.”

Virginia Secretary of Commerce and Trade, Esther Lee, opened the event with an announcement of the Virginia Founders Fund, a new seed-stage fund that increases access to venture capital in Virginia. In her comments, she emphasized the ability for software, hardware, life science, cleantech, and technology-enabled services companies to generate economic returns for the Commonwealth.

During his time on stage, Warren touched on the growth and scaling of ivWatch. “Each year we put together an update of the business plan, and we’ve been successful in the execution of our goals. A focus this year is bringing more manufacturing in-house to control quality, cost and bring more high-tech jobs to the area.”

The event brought together regional angel investor and funding groups, including 757 Angels, CIT Gap Fund, Charlottesville Angel Network, and The Launch Place, who each brought one of their most exceptional startups or emerging growth companies they’ve supported. The event focused on the dynamics between the groups and how individual successes support the statewide initiatives outlined by Secretary Lee.

To learn more about ivWatch, visit www.ivWatch.com. To learn more about 757 Angels, visit www.757angelsgroup.com.

About 757 Angels:
757 Angels is a select network of over 100 business and community leaders in the Hampton Roads region, who provide investment capital, strategic advice and mentoring to selected startup and early-stage companies to help them achieve market leadership. 757 Angels seeks dealflow from the Commonwealth of Virginia.

About ivWatch:
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLChttps://www.ivwatch.com/

MEDIA CONTACT: Amara Betoney, amara.betoney@ivwatch.com, Direct (757) 224-2606, Office (855) 489-2824 x7007, Mobile (757) 660-4949

In the News: I’m an Engineer, But I Can’t Fix Stupid

ivWatch’s Gary Warren Discusses Future of Healthcare and Device Development in MD+DI
ivWatch President and CEO, Gary Warren, offers his insights on device development and non-traditional human factors in the Medical Device and Diagnostic Industry (MD+DI) article, “I’m an Engineer, But I Can’t Fix Stupid.” In the piece, Warren reflects on his career experiences in other industries and why they shaped his philosophy around medical device development. The article focuses on the consumer power evolution in healthcare, and why companies like ivWatch must be at the forefront of interpreting consumer needs to set the standards for the medical device industry’s future. Read the full article here.

In the News: ivWatch Detects IV Infiltrations and Extravasations

Medgadget Interviews CEO of ivWatch
The editors at Medgadget set the stage for an interview with Gary Warren, president and CEO of ivWatch, by reviewing many of the recent company milestones; FDA clearances, patent grants, manufacturing operations and world-class customers. Within the interview, Warren explains the IV infiltration landscape and the company’s mission to improve the level of quality and patient safety through early detection of these events. The interview goes on to discuss at-risk patient populations, innovative hospitals who are champions for IV assessment improvement, and the need for greater awareness of the risks associated with the procedure. The interview concludes by touching on the science behind ivWatch biosensor technology and the efforts the company is making to set the new standard of care for IV therapy. Read the full interview here.

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest